Michael Gene Orand
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.6MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 29, 2022 | NIH | SBIR Phase II EP055, a non-hormonal male contraceptive:IND-enabling studies | $603K | EPPIN PHARMA, INC. |
| Apr 22, 2021 | NIH | SBIR Phase II EP055, a non-hormonal male contraceptive:IND-enabling studies | $693K | EPPIN PHARMA, INC. |
| May 20, 2019 | NIH | STTR Phase II Testing a male oral contraceptive targeting Eppin | $735K | EPPIN PHARMA, INC. |
| Dec 13, 2018 | NIH | SBIR Phase I Drug Interactions in vitro for EP055: a Non-Hormonal Male Contraceptive | $225K | EPPIN PHARMA, INC. |
| Jun 15, 2018 | NIH | STTR Phase II Testing a male oral contraceptive targeting Eppin | $1.1M | EPPIN PHARMA, INC. |
| May 18, 2015 | NIH | STTR Phase I Contraceptive testing for semen availability in male monkeys | $225K | EPPIN PHARMA, INC. |
Peer ranks
Federal funding#477
Awards as PI#315
Patents#273
Companies
- EPPIN PHARMA, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.